Literature DB >> 17872918

Comparative activity of pradofloxacin against anaerobic bacteria isolated from dogs and cats.

Peter Silley1, Bernd Stephan, Heinrich A Greife, Andrew Pridmore.   

Abstract

OBJECTIVES: To compare the intrinsic activity of pradofloxacin, a new fluoroquinolone developed for use in veterinary medicine, with other fluoroquinolones, against anaerobic bacteria isolated from dogs and cats.
METHODS: One hundred and forty-one anaerobes were isolated from dogs and cats and comparative MICs of pradofloxacin, marbofloxacin, enrofloxacin, difloxacin and ibafloxacin were determined according to standardized agar dilution methodology.
RESULTS: Pradofloxacin exerted the greatest antibacterial activity followed by marbofloxacin, enrofloxacin, difloxacin and ibafloxacin. Based on the distinctly lower MIC(50), MIC(90) and mode MIC values, pradofloxacin exhibited a higher in vitro activity than any of the comparator fluoroquinolones.
CONCLUSIONS: Pradofloxacin, a novel third-generation fluoroquinolone, has broad-spectrum anti-anaerobe activity and offers utility as single-drug therapy for mixed aerobic/anaerobic infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17872918     DOI: 10.1093/jac/dkm346

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Frequency of resistance in obligate anaerobic bacteria isolated from dogs, cats, and horses to antimicrobial agents.

Authors:  S D Lawhon; A Taylor; V R Fajt
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

2.  Comparative activity of pradofloxacin, enrofloxacin, and azithromycin against Bartonella henselae isolates collected from cats and a human.

Authors:  Silpak Biswas; Ricardo G Maggi; Mark G Papich; Daniel Keil; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

Review 3.  Microbial transformations of antimicrobial quinolones and related drugs.

Authors:  Igor A Parshikov; John B Sutherland
Journal:  J Ind Microbiol Biotechnol       Date:  2012-09-25       Impact factor: 3.346

4.  Activity of pradofloxacin against Porphyromonas and Prevotella spp. Implicated in periodontal disease in dogs: susceptibility test data from a European multicenter study.

Authors:  Bernd Stephan; Heinrich A Greife; Andrew Pridmore; Peter Silley
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

5.  Pharmacokinetic study on pradofloxacin in the dog - comparison of serum analysis, ultrafiltration and tissue sampling after oral administration.

Authors:  Gregor Hauschild; Karl Rohn; Eva Engelhardt; Martin Sager; Jendrik Hardes; Georg Gosheger
Journal:  BMC Vet Res       Date:  2013-02-14       Impact factor: 2.741

6.  Pharmacokinetics of marbofloxacin administered via intravenous regional limb perfusion in dairy cows: evaluation of two different tourniquets.

Authors:  Gianluca Celani; Serena Maria Rita Tulini; Camilla Montesano; Daniela Zezza; Manuel Sergi; Vincenzo Varasano; Carlo Maria Mortellaro; Dario Compagnone; Michele Amorena; Lucio Petrizzi
Journal:  Vet Rec Open       Date:  2017-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.